These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.
- Lacy GL, Adams DM, Hellstrom WJG. (2002). “Intralesional Interferon-Alpha-2b for the Treatment of Peyronie’s Disease.” International Journal of Impotence Research 14 (5): 336–39. http://www.ncbi.nlm.nih.gov/pubmed/12454683. (PDF)
- Pittet B, Rubbia-Brandt L, Desmouliere A, Sappino AP, Roggero P, Guerret S, Grimaud JA, Lacher R, Montandon D, Gabbiani G. (1994). “Effect of Gamma-Interferon on the Clinical and Biologic Evolution of Hypertrophic Scars and Dupuytren’s Disease: An Open Pilot Study.” Plast Reconstr Surg 93 (6): 1224–35.
- Sanders JL, Dodd C, Ghahary A, Scott PG, Tredget EE. (1999). “The Effect of Interferon-alpha2b on an in Vitro Model Dupuytren’s Contracture.” J Hand Surg Am 24 (3): 578–85. (PDF)
- Tanaka K, Sano K, Yuba K, Katsumura K, Nakano T, Kobayashi M, Ikeda T, Abe M. (2003). “Inhibition of Induction of Myofibroblasts by Interferon Gamma in a Human Fibroblast Cell Line.” Int Immunopharmacol 3 (9): 1273–80. (PDF)